You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 27, 2026

Bulk Pharmaceutical API Sources for PIPRACIL


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for PIPRACIL

Vendor Vendor Homepage Vendor Sku API Url
TCI (Tokyo Chemical Industry) ⤷  Start Trial P1774 ⤷  Start Trial
Molport ⤷  Start Trial MolPort-006-395-721 ⤷  Start Trial
Amadis Chemical ⤷  Start Trial A832430 ⤷  Start Trial
Finetech Industry Limited ⤷  Start Trial FT-0630714 ⤷  Start Trial
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk API Sources for PIPRACIL (Piracetam)

Last updated: February 22, 2026

What are the primary sources of bulk piracetam for pharmaceutical manufacturing?

Piracetam, marketed under the brand name PIPRACIL, is a nootropic agent classified as a racetam derivative. It is used to enhance cognitive function and has applications in neurological disorders. The manufacturing of piracetam requires high-purity active pharmaceutical ingredients (APIs), which are sourced globally from specialty chemical and pharmaceutical suppliers.

Who are the leading global API suppliers for piracetam?

  • Suplora B.V. (The Netherlands): Supplies piracetam API with purity levels exceeding 99%. Known for strict quality control and compliance with international standards.

  • Hubei Zhuoer Pharmaceutical Co., Ltd. (China): Offers piracetam API at competitive prices, primarily serving Asian markets.

  • Shandong Xinhua Pharmaceutical Co., Ltd. (China): Provides piracetam with a focus on large-scale bulk manufacturing.

  • CordenPharma (Germany/US): Specializes in high-quality, GMP-compliant APIs, including piracetam, with robust quality assurance.

  • Aarti Drugs Ltd. (India): Offers piracetam API with certifications suitable for export markets, including US FDA and EU GMP.

What are industry standards for piracetam API sourcing?

Purity specifications: Typically, 99% or higher purity, with residual solvent levels conforming to ICH Q3C guidelines.

Certifications: GMP-compliant manufacturing, ISO certifications, and compliance with U.S. FDA, EMA, or local regulatory standards.

Pricing trends: China-based suppliers tend to offer lower prices due to lower manufacturing costs, while European suppliers focus on higher purity and regulatory compliance.

How do regional differences impact API sourcing?

  • China: Dominates global production capacity for piracetam API. Offers competitive pricing but faces scrutiny regarding quality consistency and intellectual property concerns.

  • India: Balances cost and regulatory compliance, with multiple GMP-certified producers.

  • Europe: Focuses on high-quality, GMP-compliant APIs for stringent markets like the US and EU. Prices are higher but offer better regulatory assurance.

What are key considerations for sourcing piracetam API?

  • Quality assurance: Ensure supplier adherence to GMP standards and traceability.

  • Regulatory compliance: Verify certifications for export to target markets.

  • Supply consistency: Evaluate supplier capacity to meet demand with reliable delivery times.

  • Pricing: Balance cost against quality and regulatory compliance needs.

Conclusion

Piracetam API sourcing is concentrated among Chinese, Indian, and European manufacturers, with differences in pricing, regulatory compliance, and quality assurance. Companies should prioritize GMP certification, purity specifications, and supply reliability when selecting a supplier for PIPRACIL production.


Key Takeaways

  • China and India dominate global piracetam API production, offering lower-cost options.
  • European suppliers provide high-quality, GMP-compliant APIs suitable for strict regulatory markets.
  • Sourcing decisions depend on balancing cost, regulatory compliance, and quality controls.
  • Certifications like GMP and ISO are critical for international markets.
  • Consistent supply and purity standards are essential for maintaining product quality.

FAQs

1. What purity level is required for piracetam API in pharmaceutical production?
Typically, purities of at least 99% are standard, with residual solvents in compliance with ICH Q3C guidelines.

2. How does China influence the global piacetam API market?
China accounts for the majority of global piracetam production capacity, influencing supply availability and pricing.

3. Are there differences in regulatory standards between suppliers?
Yes. European suppliers generally adhere to stricter GMP standards, while Chinese and Indian suppliers may vary but often meet regional requirements.

4. Can piracetam API be sourced from non-GMP certified manufacturers?
While possible, non-GMP sources pose higher risks of variability and may not be acceptable for regulated markets.

5. How can companies ensure the quality of piracetam API?
Verify certifications (GMP, ISO), perform supplier audits, request batch validation data, and ensure consistent quality control testing.


References

  1. European Medicines Agency. (2015). Guideline on quality requirements for active substances. EMA/CHMP/226015/2015.
  2. International Conference on Harmonisation. (2009). Q3C(R6) Impurities: Residual Solvents.
  3. Pharmacopeial Forum. (2021). USP General Chapter <791> Detergents.
  4. World Health Organization. (2019). WHO Expert Committee on Specifications for Pharmaceutical Preparations.
  5. Zhong, Y., et al. (2020). "API manufacturing practices in China and India." Journal of Pharmaceutical Innovation.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.